AMCP Review |
|
During this year's Academy of Managed Care Pharmacy (AMCP) 27th Annual Meeting & Expo, national experts tackled critical topics in the managed care pharmacy arena. Access the information you may have missed in this post-conference installment. |
Highlights |
|
The explosive growth in the specialty drug sector challenges the sustainability of the U.S. health system because there are not enough loss-of-earnings offsets to cover the increases. Read more. |
|
Clinical pharmacists integrated into patient care teams have the potential to improve medication measures as well as support cost-effective medication use. Read more. |
|
Managed care pharmacists should track their performance on medication measures included in Medicare’s new Five-Star Quality Rating System to help guide improvement efforts. Read more. |
|
The incentives unfolding in both the public and private insurance markets that include providers assuming more financial risk will impact prescribing decisions for specialty pharmaceuticals. Read more. |
|
|
We welcome your feedback!
Please send your comments to:
Tracey Walker
Content Manager
Formulary Watch
[email protected] |
DISCLAIMER:
This information has been independently developed and provided by the editors of Formulary Watch. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
